Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis--a longitudinal MRI study.
about
Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study.Width of 3. Ventricle: reference values and clinical relevance in a cohort of patients with relapsing remitting multiple sclerosis.Clinical relevance of brain volume measures in multiple sclerosis.MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.The puzzle of multiple sclerosis: gray matter finds its place.Neuroimaging in multiple sclerosis: neurotherapeutic implications.Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis PatientsGray Matter Pathology in MS: Neuroimaging and Clinical Correlations.The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.An animal model of cortical and callosal pathology in multiple sclerosis.The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis.Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis.Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.Grey matter atrophy is associated with disability increase in natalizumab-treated patients.A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study.Longitudinal gray matter changes in multiple sclerosis--differential scanner and overall disease-related effects.Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry
P2860
Q30449269-0A0B651E-58D0-49A4-A20F-60B5BCBF30AAQ30454179-1E61F111-3319-485B-B1F9-B537A4A1AFDCQ30738659-6BBA968C-0645-4368-ACE0-EA29FE98ACF8Q30798662-12FFDFF1-1A91-488F-A816-DA0295473A12Q33352371-D696DDE6-5AB7-40B9-9DC3-A1A69F93D333Q33806032-82F08310-CB5B-4C68-995D-CEB8E81097CBQ35744057-85535AA7-78EB-4B86-8E53-F540BAFB3478Q37002903-AC94B03A-BBB6-4328-9CAF-AA9955475037Q37459099-9B105449-B5C1-4564-889B-EA3029EF52E0Q37584143-C6E5F23E-1542-4681-933F-FFC67703D77FQ37596025-6DCA7038-3B56-4103-B100-AF09D1FCBCECQ41020615-2122255D-FED7-4D51-B5EB-E0D76C442600Q42503511-63F88765-832D-4B39-B564-D5D4FB8AB174Q48572300-6F1DD72D-702B-46E6-B60F-FAEAAA66C2B7Q48651177-9BDE127A-8E4E-408D-886E-80209C8D4FF0Q48770738-28AC1878-078B-444F-B57D-14980BDE9E5AQ50229425-D8CD30BF-CD83-41A5-9515-211F8365CE74Q51468551-782E5187-518F-47D5-8291-5F0893B7E6B5Q51822950-DFCFD044-0D3A-4FF3-B619-6CBC2FF025D4Q58704396-2810A388-1691-40DF-A9CD-A7A0FE2FC4F9
P2860
Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis--a longitudinal MRI study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Effect of immunomodulatory med ...... sis--a longitudinal MRI study.
@en
Effect of immunomodulatory med ...... sis--a longitudinal MRI study.
@nl
type
label
Effect of immunomodulatory med ...... sis--a longitudinal MRI study.
@en
Effect of immunomodulatory med ...... sis--a longitudinal MRI study.
@nl
prefLabel
Effect of immunomodulatory med ...... sis--a longitudinal MRI study.
@en
Effect of immunomodulatory med ...... sis--a longitudinal MRI study.
@nl
P2093
P50
P1433
P1476
Effect of immunomodulatory med ...... sis--a longitudinal MRI study.
@en
P2093
Achim Gass
Ernst-Wilhelm Radue
Hanspeter Egger
Kerstin Bendfeldt
Nicole Mueller-Lenke
Niklaus Denier
Pascal Kuster
Patrick Loetscher
Stefan Traud
Yvonne Naegelin
P304
P356
10.1016/J.BRAINRES.2010.02.035
P407
P577
2010-02-16T00:00:00Z